HeartBeam sets up $25M at-the-market stock program
HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC as sales agent.
Rhea-AI Filing Summary
HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC as sales agent. Under this agreement, HeartBeam may sell from time to time up to $25,000,000 of common stock through at-the-market offerings under its existing shelf Registration Statement on Form S-3. The company filed a prospectus supplement dated August 14, 2026 covering these sales. Titan Partners will receive a commission of up to 3% of the gross sales price per share and has been provided customary indemnification and contribution rights.
Positive
- None.
Negative
- None.
Filing Explained
The
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
ATM Program Size: $25,000,000 of common stock
Sales Agent Commission: Up to 3% of gross sales price per share
Registration Statement: Form S-3 (Reg. No. 333-293307)
+1 more
4 metrics
ATM Program Size
$25,000,000 of common stock
Maximum aggregate amount of shares that may be sold under the Sales Agreement
Sales Agent Commission
Up to 3% of gross sales price per share
Commission payable to Titan Partners Securities LLC on shares sold
Registration Statement
Form S-3 (Reg. No. 333-293307)
Shelf registration statement under which the Shares may be sold
Prospectus Supplement Date
August 14, 2026
Date of the Rule 424(b) prospectus supplement covering the Shares
Key Terms
At-The-Market Equity Offering Sales Agreement, shelf Registration Statement on Form S-3, prospectus supplement, indemnification and contribution rights
4 terms
At-The-Market Equity Offering Sales Agreement financial
"entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners"
shelf Registration Statement on Form S-3 regulatory
"through the sales agent pursuant to the Company’s shelf Registration Statement on Form S-3"
A shelf registration statement on Form S-3 is a pre-approved filing with the Securities and Exchange Commission that lets an eligible public company register securities in advance and sell them later in one or more offerings without repeating the full registration process. Think of it like a pre-approved funding line: it gives management the flexibility to raise capital quickly when market conditions are right, a move that can affect share supply, dilution and investor returns, so investors monitor it as a signal of potential financing activity.
prospectus supplement regulatory
"The Company has filed a prospectus supplement, dated August 14, 2026"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
indemnification and contribution rights regulatory
"The Company has provided the sales agent with customary indemnification and contribution rights"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HeartBeam, Inc. (BEAT) announce on August 14, 2026?
HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC, allowing it to sell up to $25,000,000 of common stock over time under its existing shelf registration.
What is the size of HeartBeam (BEAT)'s new at-the-market offering program?
The program permits HeartBeam to sell up to $25,000,000 of its common stock. Shares may be issued and sold from time to time in at-the-market offerings under a prospectus supplement dated August 14, 2026.
Who is the sales agent for HeartBeam (BEAT)'s at-the-market equity offering?
Titan Partners Securities LLC is the sales agent for the at-the-market offering. It will facilitate sales of HeartBeam’s common stock in at-the-market transactions pursuant to the new Sales Agreement and related prospectus supplement.
What commission will Titan Partners receive under HeartBeam (BEAT)'s Sales Agreement?
Titan Partners will receive a commission of up to 3% of the gross sales price per share for any HeartBeam common stock sold under the At-The-Market Equity Offering Sales Agreement, plus customary indemnification and contribution protections.
What legal opinions and consents are filed with HeartBeam (BEAT)'s ATM Sales Agreement?
HeartBeam filed a Sales Agreement as Exhibit 1.1, an opinion of Lucosky Brookman LLP as Exhibit 5.1, and a related consent as Exhibit 23.1, along with an Inline XBRL cover page data file.
AI-generated analysis. How Rhea-AI works. Not financial advice.
